Service Corporation International exhibits stable revenue growth of 3.6% in Q2 2026, supported by resilient gross margins near 25% despite the cremation mix shift. The company generates strong cash flow, with operating cash flow exceeding net income by 1.91x i...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth has been stable at 1-4% annually, with Q2 2026 gross margin at 24.8% and operating margin at 21.0%, reflecting effective cost control despite cremation headwinds.
SCI shares are trading at a higher forward P/E multiple (19.5x) compared to historical levels (16.8x), suggesting market optimism about future earnings.
Despite volume challenges, SCI's ability to maintain margins suggests strong pricing power in the funeral services industry.
The company continues to pay quarterly dividends ($0.34 per share) even amid earnings volatility, demonstrating commitment to shareholder returns.
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 29, 2026 | $0.90+1.4% vs $0.89 | $1.1B+1.9% vs $1.1B |
Q2 2026 Apr 29, 2026 | $0.97-3.0% vs $1.00 | $1.1B+0.2% vs $1.1B |
Q1 2026 Feb 11, 2026 | $1.14+0.0% vs $1.14 | $1.1B-0.5% vs $1.1B |
Q4 2025 Oct 29, 2025 | $0.87+4.8% vs $0.83 | $1.1B-5.3% vs $1.1B |
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI invited to deliver keynote address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology.
Service Corporation International (NYSE: SCI - Get Free Report)'s stock price crossed below its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $81.43 and traded as low as $80.75. Service Corporation International shares last traded at $82.87, with a volume of 654,474 shares trading hands. Analyst
Toronto, Ontario, August 31, 2026 – TheNewswire – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage pharmaceutical company and a subsidiary of SciSparc Ltd. (Nasdaq: SPRC), today announced continued advancement in participant enrollment for its clinical trial assessing its innovative SCI-210 treatment for symptoms associated with autism spectrum disorder (“ ASD ”). The clinical trial, conducted at Soroka Medical Center in Israel, is a double-blind, randomized, placebo-controlled study evaluating the safety and efficacy of SCI-210 in children diagnosed with ASD. To date, 26 children have been enrolled, marking strong progress toward the planned total of 60 children between the ages of five and 18, each of whom will receive treatment over a 20-week period.
Bank of New York Mellon Corp bought a new stake in Service Corporation International (NYSE: SCI) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,065,888 shares of the company's stock, valued at approximately $80,965,000. Bank of New York Mellon Corp owned
Benchmark SCI against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Service Corporation International (SCI)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $77.85 | $10.75B | 20.49 | 2.93% | 12.59% | 32.71% | 1.65% | |
| $31.72 | $503.47M | 9.76 | 3.28% | 10.67% | 17.07% | — | |
| $19.71 | $615M | -24.95 | -16.6% | -2.65% | -5.81% | — | |
| $31.98 | $2.26B | 52.43 | -15.99% | 1.37% | 2.43% | — | |
| $394.80 | $9.5B | 1233.75 | 11.03% | 0.67% | — | — | |
| $79.02 | $51.66B | 28.73 | 5.83% | 16.77% | 5.42% | — |
Service Corporation International (SCI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Service Corporation International (SCI) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 5, 2026·SEC
Jul 29, 2026·SEC
Jul 29, 2026·SEC
Get notified when SCI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Service Corporation International (SCI) stock FAQ — growth, dividends, profitability & financials explained
Service Corporation International (SCI) reported $4.37B in revenue for fiscal year 2025. This represents a 90% increase from $2.29B in 1996.
Service Corporation International (SCI) grew revenue by 2.9% over the past year. Growth has been modest.
Yes, Service Corporation International (SCI) is profitable, generating $628.3M in net income for fiscal year 2025 (12.6% net margin).
Yes, Service Corporation International (SCI) pays a dividend with a yield of 1.65%. This makes it attractive for income-focused investors.
Service Corporation International (SCI) has a return on equity (ROE) of 32.7%. This is excellent, indicating efficient use of shareholder capital.
Service Corporation International (SCI) generated $706.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
